Explore the details of the Astrazeneca Pharmaceuticals Lp V. Cipla Limited case under case number 3:25-cv-00233 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
3:25-cv-00233
Filing Date
Jan 9, 2025
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
KUDOS PHARMACEUTICALS LIMITED -
ASTRAZENECA AB -
MSD INTERNATIONAL BUSINESS GMBH -
CIPLA USA, INC. -

Patents Involved in the Case

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jan 9, 2025Corporate Disclosure Statement by MSD INTERNATIONAL BUSINESS GMBH identifying Merck & Co., Inc. as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 01/09/2025)PACER Document
Jan 9, 2025Corporate Disclosure Statement by KUDOS PHARMACEUTICALS LIMITED identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 01/09/2025)PACER Document
Jan 9, 2025Corporate Disclosure Statement by ASTRAZENECA AB identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 01/09/2025)PACER Document
Jan 9, 2025Corporate Disclosure Statement by ASTRAZENECA UK LIMITED identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 01/09/2025)PACER Document
Jan 9, 2025Corporate Disclosure Statement by ASTRAZENECA PHARMACEUTICALS LP identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 01/09/2025)PACER Document
Jan 9, 2025COMPLAINT against CIPLA LIMITED, CIPLA USA, INC. ( Filing and Admin fee $ 405 receipt number ANJDC-15928486), Related Case Selected, filed by KUDOS PHARMACEUTICALS LIMITED, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA AB, ASTRAZENECA UK LIMITED, MSD INTERNATIONAL BUSINESS GMBH. (Attachments: # 1 Exhibit A, # 2 Certification (Rule 11.2), # 3 Civil Cover Sheet)(CHEVALIER, CHARLES) (Entered: 01/09/2025)PACER Document
Jan 10, 2025SUMMONS ISSUED as to CIPLA LIMITED, CIPLA USA, INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (dmr3) (Entered: 01/10/2025)PACER Document
Jan 10, 2025AO120 Patent Form filed. (dmr3, ) (Entered: 01/10/2025)PACER Document
Jan 22, 2025WAIVER OF SERVICE Returned Executed by KUDOS PHARMACEUTICALS LIMITED, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA AB, ASTRAZENECA UK LIMITED, MSD INTERNATIONAL BUSINESS GMBH. CIPLA USA, INC. waiver sent on 1/10/2025, answer due 3/11/2025. (CHEVALIER, CHARLES) (Entered: 01/22/2025)PACER Document
Jan 22, 2025WAIVER OF SERVICE Returned Executed by KUDOS PHARMACEUTICALS LIMITED, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA AB, ASTRAZENECA UK LIMITED, MSD INTERNATIONAL BUSINESS GMBH. CIPLA LIMITED waiver sent on 1/10/2025, answer due 3/11/2025. (CHEVALIER, CHARLES) (Entered: 01/22/2025)PACER Document
Jan 9, 2025Judge Robert Kirsch and Magistrate Judge Tonianne J. Bongiovanni added. (dmr3)PACER Document